Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 99 member B (FAM99B) is a liver-specific long non-coding RNA (lncRNA), highly expressed in hepatic tissue and markedly downregulated in hepatocellular carcinoma (HCC)[2][3][4][7]. FAM99B acts as a tumor suppressor, influencing cell proliferation, migration, invasion, and metabolic pathways associated with cancer progression[2][3][4]. Its decreased expression correlates with increased HCC malignancy and poor prognosis, making it a promising biomarker for diagnosis and prediction of HCC outcomes[2]. FAM99B does not encode a protein and is not a pharmacological target but may provide mechanistic and diagnostic insights into liver cancer biology[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 99 member B (FAM99B).